Australia's most trusted
source of pharma news
Friday, 03 May 2024
Posted 19 April 2024 AM
Yet another filing for Eli Lilly's Mounjaro is on the horizon - but this time for obstructive sleep apnoea (OSA)
Mounjaro, also known as Zepound in the US, is currently available on private script in Australia for type 2 diabetes patients and under the TGA's review for chronic weight management.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.